If you find this podcast useful please give it a rating and review on iTunes by clicking here
On today's Vox Markets Podcast: MGC Pharmaceuticals discuss their progress since listing and Alan Green on 3 Stocks
Ron Lipsky VP of Business Development & International Relations at MGC Pharmaceuticals #MXC discusses recent progress at the company after they became the first medicinal cannabis company to list on LSE a month ago.
MGC Pharmaceuticals Ltd (LSE: MXC, ASX: MXC) is a European based bio-pharma company developing and supplying affordable standardised phytocannabinoid derived medicines to patients globally. The Company's founders were key figures in the global medical cannabis industry and the core business strategy is to develop and supply high quality phytocannabinoid derived medicines for the growing demand in the medical markets in Europe, North America and Australasia. MGC Pharma has a robust product offering targeting two widespread medical conditions - epilepsy and dementia - and has further products in the development pipeline.
Alan Green CEO of Brand Communications talks about:
Smart Metering Systems #SMS
Logistics Development Group #LDG
Non-Fungible Tokens.
(Interview starts at 14 minutes 12 seconds)